Literature DB >> 21369846

Use of gene-modified keratinocytes and fibroblasts to enhance regeneration in a full skin defect.

Jörn Andreas Lohmeyer1, Fang Liu, Stefan Krüger, Werner Lindenmaier, Frank Siemers, Hans-Günther Machens.   

Abstract

BACKGROUND: With the development of cell-based gene transfer techniques, genetically modified human keratinocytes (Kc) and fibroblasts (Fb) have been proven to be a better choice in wound repair.
METHODS: This study was designed to construct in one step a gene-modified artificial skin by a genetically engineered Kc expressing PDGF-BB and Fb expressing VEGF(165) and bFGF. The wound healing effect in a full-thickness wound model was then observed. Unmodified artificial skin served as control. On the post-operative days 7, 14, and 21, residual wound area was calculated and skin wound tissues were subjected to biopsy for further investigation.
RESULTS: Compared with unmodified artificial skin, gene-modified artificial skin resulted in a reduced wound contraction and a well-organized human epidermis and better formed dermis.
CONCLUSIONS: The results suggest that our two-layer, gene-modified artificial skin improved both vascularization and epidermalization for skin regeneration. This technique could bring about a new approach in the treatment of burns and chronic wounds.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21369846     DOI: 10.1007/s00423-011-0761-3

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  34 in total

Review 1.  Tissue engineering of the vascular system: from capillaries to larger blood vessels.

Authors:  L Germain; M Rémy-Zolghadri; F Auger
Journal:  Med Biol Eng Comput       Date:  2000-03       Impact factor: 2.602

2.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

3.  Transplanted mesenchymal stem cells are effective for skin regeneration in acute cutaneous wounds.

Authors:  Hiroko Satoh; Kazuo Kishi; Takara Tanaka; Yoshiaki Kubota; Tatsuo Nakajima; Yoshikiyo Akasaka; Toshiharu Ishii
Journal:  Cell Transplant       Date:  2004       Impact factor: 4.064

Review 4.  The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review.

Authors:  Ruben Y Kannan; Henryk J Salacinski; Kevin Sales; Peter Butler; Alexander M Seifalian
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

5.  Improved survival of rat ischemic cutaneous and musculocutaneous flaps after VEGF gene transfer.

Authors:  Andrea Antonini; Serena Zacchigna; Giovanni Papa; Federico Novati; Michele Pascone; Mauro Giacca
Journal:  Microsurgery       Date:  2007       Impact factor: 2.425

Review 6.  Tissue engineering and biomaterials in regenerative medicine.

Authors:  Katherine Nolan; Yoann Millet; Camillo Ricordi; Cherie L Stabler
Journal:  Cell Transplant       Date:  2008       Impact factor: 4.064

7.  Systems for therapeutic angiogenesis in tissue engineering.

Authors:  S Soker; M Machado; A Atala
Journal:  World J Urol       Date:  2000-02       Impact factor: 4.226

Review 8.  Wound healing: the role of growth factors.

Authors:  Anna T Grazul-Bilska; Mary Lynn Johnson; Jerzy J Bilski; Dale A Redmer; Lawrence P Reynolds; Ahmed Abdullah; Kay M Abdullah
Journal:  Drugs Today (Barc)       Date:  2003-10       Impact factor: 2.245

9.  Cell suspension cultures of allogenic keratinocytes are efficient carriers for ex vivo gene transfer and accelerate the healing of full-thickness skin wounds by overexpression of human epidermal growth factor.

Authors:  Jan Jeroen Vranckx; Daniela Hoeller; Patrik E M Velander; Christoph F P Theopold; Nicola Petrie; Akira Takedo; Elof Eriksson; Feng Yao
Journal:  Wound Repair Regen       Date:  2007 Sep-Oct       Impact factor: 3.617

10.  A randomized, controlled trial of Promogran (a collagen/oxidized regenerated cellulose dressing) vs standard treatment in the management of diabetic foot ulcers.

Authors:  Aristidis Veves; Peter Sheehan; Hau T Pham
Journal:  Arch Surg       Date:  2002-07
View more
  5 in total

Review 1.  Methodologies in creating skin substitutes.

Authors:  Mathew N Nicholas; Marc G Jeschke; Saeid Amini-Nik
Journal:  Cell Mol Life Sci       Date:  2016-05-06       Impact factor: 9.261

2.  Gelatin-chondroitin-6-sulfate-hyaluronic acid scaffold seeded with vascular endothelial growth factor 165 modified hair follicle stem cells as a three-dimensional skin substitute.

Authors:  Renfu Quan; Xuan Zheng; Shichao Xu; Liang Zhang; Disheng Yang
Journal:  Stem Cell Res Ther       Date:  2014-10-20       Impact factor: 6.832

3.  High Efficiency Low Cost Fibroblast Nucleofection for GMP Compatible Cell-based Gene Therapy.

Authors:  Ziyang Zhang; Alex Slobodianski; Astrid Arnold; Jessica Nehlsen; Ursula Hopfner; Arndt F Schilling; Tatjana Perisic; Hans-Günther Machens
Journal:  Int J Med Sci       Date:  2017-07-19       Impact factor: 3.738

4.  Biodegradable poly (lactic acid-co-glycolic acid) scaffolds as carriers for genetically-modified fibroblasts.

Authors:  Tatjana Perisic; Ziyang Zhang; Peter Foehr; Ursula Hopfner; Kathrin Klutz; Rainer H Burgkart; Alexei Slobodianski; Moritz Goeldner; Hans-Günther Machens; Arndt F Schilling
Journal:  PLoS One       Date:  2017-04-05       Impact factor: 3.240

Review 5.  Alteration of skin properties with autologous dermal fibroblasts.

Authors:  Rajesh L Thangapazham; Thomas N Darling; Jon Meyerle
Journal:  Int J Mol Sci       Date:  2014-05-13       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.